References
  1. Andrassy KM (2013) Comments on ’KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease’. Kidney Int 84: 622-623.
  2. Obrador GT, Levin A (2019) CKD Hotspots: Challenges and Areas of Opportunity. Semin Nephrol39: 308-314.
  3. Glassock RJ, Warnock DG, Delanaye P (2017) The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol 13: 104-114.
  4. Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, et al. (2015) A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88: 950-957.
  5. Zhang L, Wang F, Wang L, Wang W, Liu B, et al. (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379: 815-822.
  6. Neild GH (2017) Life expectancy with chronic kidney disease: an educational review. Pediatr Nephrol32: 243-248.
  7. van Oosten MJM, Logtenberg SJJ, Leegte MJH, Bilo HJG, Mohnen SM, et al. (2019) Age-related difference in health care use and costs of patients with chronic kidney disease and matched controls: analysis of Dutch health care claims data.Nephrol Dial Transplant .
  8. Echouffo-Tcheugui JB, Narayan KM, Weisman D, Golden SH, Jaar BG (2016) Association between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis. Diabet Med 33: 1615-1624.
  9. Spijkerman AM, Dekker JM, Nijpels G, Adriaanse MC, Kostense PJ, et al. (2003) Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. Diabetes Care26: 2604-2608.
  10. Levey AS, Coresh J (2012) Chronic kidney disease. Lancet 379: 165-180.
  11. Markus MRP, Ittermann T, Baumeister SE, Huth C, Thorand B, et al. (2018) Prediabetes is associated with microalbuminuria, reduced kidney function and chronic kidney disease in the general population: The KORA (Cooperative Health Research in the Augsburg Region) F4-Study. Nutr Metab Cardiovasc Dis 28: 234-242.
  12. Jadhakhan F, Marshall T, Ryan R, Gill P (2018) Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records. BMC Nephrol19: 42.
  13. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med15: 539-553.
  14. (2015) (2) Classification and diagnosis of diabetes. Diabetes Care 38 Suppl: S8-s16.
  15. Nazimek-Siewniak B, Moczulski D, Grzeszczak W (2002) Risk of macrovascular and microvascular complications in Type 2 diabetes: results of longitudinal study design. J Diabetes Complications 16: 271-276.
  16. de Boer IH, Zelnick L, Afkarian M, Ayers E, Curtin L, et al. (2016) Impaired Glucose and Insulin Homeostasis in Moderate-Severe CKD. J Am Soc Nephrol 27: 2861-2871.
  17. Bi Y, Lu J, Wang W, Mu Y, Zhao J, et al. (2014) Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study. J Diabetes 6: 147-157.
  18. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21: 2191-2192.
  19. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, et al. (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17: 2937-2944.
  20. (2014) Standards of medical care in diabetes–2014. Diabetes Care 37 Suppl 1: S14-80.
  21. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet380: 2095-2128.
  22. Drawz P, Rahman M (2015) Chronic kidney disease. Ann Intern Med 162: Itc1-16.
  23. Kazancioğlu R (2013) Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011) 3: 368-371.
  24. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, et al. (2000) Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 23: 1113-1118.
  25. Schöttker B, Brenner H, Koenig W, Müller H, Rothenbacher D (2013) Prognostic association of HbA1c and fasting plasma glucose with reduced kidney function in subjects with and without diabetes mellitus. Results from a population-based cohort study from Germany. Prev Med 57: 596-600.
  26. Michishita R, Matsuda T, Kawakami S, Tanaka S, Kiyonaga A, et al. (2017) The joint impact of habitual exercise and glycemic control on the incidence of chronic kidney disease (CKD) in middle-aged and older males. Environ Health Prev Med 22: 76.
  27. Davis TA, Klahr S, Karl IE (1987) Glucose metabolism in muscle of sedentary and exercised rats with azotemia. Am J Physiol 252: F138-145.
  28. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98: 2005-2010.
  29. Hanssen NMJ, Scheijen J, Houben A, van de Waarenburg M, Berendschot T, et al. (2020) Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study. Diabetes Metab .
  30. Leyking S, Fliser D (2014) Insulin resistance in CKD. Clin J Am Soc Nephrol 9: 638-640.
  31. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, et al. (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174.
  32. Ma A, Liu F, Wang C, Liang K, Yan F, et al. (2018) Both insulin resistance and metabolic syndrome accelerate the progression of chronic kidney disease among Chinese adults: results from a 3-year follow-up study. Int Urol Nephrol50: 2239-2244.
  33. Huh JH, Yadav D, Kim JS, Son JW, Choi E, et al. (2017) An association of metabolic syndrome and chronic kidney disease from a 10-year prospective cohort study.Metabolism 67: 54-61.
  34. Bastürk T, Unsal A (2011) Is insulin resistance a risk factor for the progression of chronic kidney disease? Kidney Blood Press Res 34: 111-115.
  35. Rao A, Pandya V, Whaley-Connell A (2015) Obesity and insulin resistance in resistant hypertension: implications for the kidney. Adv Chronic Kidney Dis 22: 211-217.
  36. Cybulsky AV (2010) Endoplasmic reticulum stress in proteinuric kidney disease. Kidney Int 77: 187-193.
  37. Sowers JR (2007) Metabolic risk factors and renal disease. Kidney Int 71: 719-720.
  38. Tsimihodimos V, Dounousi E, Siamopoulos KC (2008) Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am J Nephrol 28: 958-973.
  39. Samuelsson O, Attman PO, Knight-Gibson C, Larsson R, Mulec H, et al. (1998) Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.J Am Soc Nephrol 9: 1482-1488.
  40. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, et al. (1981) Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man.Diabetes 30: 219-225.
  41. Gluba A, Mikhailidis DP, Lip GY, Hannam S, Rysz J, et al. (2013) Metabolic syndrome and renal disease.Int J Cardiol 164: 141-150.
  42. Ruijgrok C, Dekker JM, Beulens JW, Brouwer IA, Coupé VMH, et al. (2018) Size and shape of the associations of glucose, HbA(1c), insulin and HOMA-IR with incident type 2 diabetes: the Hoorn Study. Diabetologia 61: 93-100.
  43. Yamanouchi M, Furuichi K, Hoshino J (2019) Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study. 42: 891-902.
  44. Harari F, Sallsten G, Christensson A, Petkovic M, Hedblad B, et al. (2018) Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort. Am J Kidney Dis 72: 381-389.
  45. Wan EYF, Yu EYT, Chin WY, Fong DYT, Choi EPH, et al. (2019) Burden of CKD and Cardiovascular Disease on Life Expectancy and Health Service Utilization: a Cohort Study of Hong Kong Chinese Hypertensive Patients. J Am Soc Nephrol 30: 1991-1999.